On behalf of the Board of Directors of ICM Pharma Pte Ltd, I am pleased to announce the appointment of Mr Nandiraju Manohar (Manu) as Chief Executive Officer with effect 5 September 2016.
Manu joins us with a rich experience of over 20 years in the pharmaceutical industry, having served reputed organisations such as SmithKline, Aurobindo, Bilcare, and prior to joining us, as Managing Director of Drug Houses of Australia Pte Ltd and Director of Ascent Pharmahealth Asia Pte Ltd (Teva group companies).
Qualified with a Masters in Pharmacy and Masters of Business Administration, he is also a certified graduate in Management research from University of South Australia, Brisbane.
His techno-commercial foundation encompasses hands on experience in many key functionalities of the pharma value chain from R&D, QA, SCM, manufacturing scale-ups (6+ years) augmented by an international business experience (15+ years) that spans Asia Pacific, Europe and Africa.
I take this opportunity to thank you for your continued support and assure our prompt services so as to take our relationship to greater heights.
Dr Stuart Koe
About ICM Pharma
Founded in 1970, ICM Pharma is a Singapore-based, GMP-certified pharmaceutical manufacturer that develops, manufactures and markets a range of OTC and generic pharmaceuticals, cosmetics and disinfectants. ICM Pharma specialises in liquid mixtures, creams and ointments, and is a leading supplier to public and private healthcare institutions, and clinics in Singapore. ICM Pharma’s over-the-counter range of “Minor Ailment Remedies” are sold in pharmacies nationwide, including award-winning national brand leaders such as Growell, Lactus and Aqurea.
For more information about ICM Pharma, please visit www.icmpharma.com.
For a PDF version of this announcement, please click here.